patient_id	feature_display	tested_subfeature	therapy_name	n_mut	n_wt	n_mut_tested	n_wt_tested	mut_ic50_median	mut_ic50_mean	mut_ic50_std	wt_ic50_median	wt_ic50_mean	wt_ic50_std	pvalue_mww	statistic
MO_1096	AKT1 p.E17K (Missense)	AKT1	MK-2206	118	1705	59	712	24.462	92.919	184.213	18.931	70.13	197.902	0.207	18928.0
MO_1096	AKT1 p.E17K (Missense)	AKT1 Somatic Variant	MK-2206	29	1794	16	755	17.151	55.465	78.958	19.172	72.222	198.62	0.597	6506.0
MO_1096	AKT1 p.E17K (Missense)	AKT1 Somatic Variant Missense	MK-2206	25	1798	15	756	14.618	55.691	81.724	19.222	72.195	198.489	0.453	6312.0
MO_1096	AKT1 p.E17K (Missense)	AKT1 Somatic Variant Missense p.E17K	MK-2206	2	1821	2	769	21.614	21.614	2.729	19.158	72.005	197.108	0.872	718.0
MO_1096	CD44--SLC45A3 Fusion	CD44	Sorafenib	89	1734	46	711	10.808	27.168	44.495	11.526	37.925	109.856	0.372	17635.5
MO_1096	CD44--SLC45A3 Fusion	SLC45A3	Sorafenib	76	1747	41	716	8.069	29.259	77.835	11.848	37.73	108.503	0.026	17713.5
MO_1096	CD44--SLC45A3 Fusion	CD44 Fusions	Sorafenib	3	1820	3	754	1.951	4.651	5.543	11.518	37.401	107.238	0.048	1879.0
MO_1096	CD44--SLC45A3 Fusion	SLC45A3 Fusions	Sorafenib	1	1822	1	756	467.394	467.394		11.473	36.702	105.964	0.089	6.0
MO_1096	CD44--SLC45A3 Fusion	CD44--SLC45A3	Sorafenib	0	1823	0	757				11.486	37.271	107.045	nan	
